Download Files:
Atuzabrutinib
SKU
HY-132808-1 mg
Category Reference compound
Tags Btk, Inflammation/Immunology, Protein Tyrosine Kinase/RTK
$230 – $5,000
Products Details
Product Description
– Atuzabrutinib (SAR 444727) is a potent, selective reversible inhibitor of Btk (Bruton’s tyrosine kinase) inhibitor. Atuzabrutinib inhibits neutrophil recruitment via inhibition of macrophage antigen-1 signalling[1].
Web ID
– HY-132808
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C30H30FN7O2
References
– [1]Herter JM, et al. PRN473, an inhibitor of Bruton’s tyrosine kinase, inhibits neutrophil recruitment via inhibition of macrophage antigen-1 signalling. Br J Pharmacol. 2018;175(3):429-439.
CAS Number
– 1581714-49-9
Molecular Weight
– 539.60
SMILES
– NC1=C2C(N([C@H]3CN(CCC3)C(/C(C#N)=C/C(C)(C)C)=O)N=C2C4=C(C=C(C=C4)OC5=CC=CC=C5)F)=NC=N1
Clinical Information
– Phase 2
Research Area
– Inflammation/Immunology
Solubility
– DMSO : 100 mg/mL (ultrasonic)
Target
– Btk
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.